Stockreport

Kairos Pharma Announces New Department of Defense Funding for Research of ENV205

Kairos Pharma, Ltd.  (KAPA) 
PDF LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announces that through its academic partnership [Read more]